These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 34686680)
1. Long-term protective immunity induced by an adjuvant-containing live-attenuated AIDS virus. Okamura T; Shimizu Y; Asaka MN; Kanuma T; Tsujimura Y; Yamamoto T; Matsuo K; Yasutomi Y NPJ Vaccines; 2021 Oct; 6(1):124. PubMed ID: 34686680 [TBL] [Abstract][Full Text] [Related]
2. Simian immunodeficiency virus SIVmac239 infection and simian human immunodeficiency virus SHIV89.6P infection result in progression to AIDS in cynomolgus macaques of Asian origin. Okamura T; Tsujimura Y; Soma S; Takahashi I; Matsuo K; Yasutomi Y J Gen Virol; 2016 Dec; 97(12):3413-3426. PubMed ID: 27902330 [TBL] [Abstract][Full Text] [Related]
3. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques. Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225 [TBL] [Abstract][Full Text] [Related]
4. An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS. Wang SW; Bertley FM; Kozlowski PA; Herrmann L; Manson K; Mazzara G; Piatak M; Johnson RP; Carville A; Mansfield K; Aldovini A AIDS Res Hum Retroviruses; 2004 Aug; 20(8):846-59. PubMed ID: 15320989 [TBL] [Abstract][Full Text] [Related]
5. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus. Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422 [TBL] [Abstract][Full Text] [Related]
7. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693 [TBL] [Abstract][Full Text] [Related]
8. Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. Reimann KA; Parker RA; Seaman MS; Beaudry K; Beddall M; Peterson L; Williams KC; Veazey RS; Montefiori DC; Mascola JR; Nabel GJ; Letvin NL J Virol; 2005 Jul; 79(14):8878-85. PubMed ID: 15994781 [TBL] [Abstract][Full Text] [Related]
9. Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239. Genescà M; Rourke T; Li J; Bost K; Chohan B; McChesney MB; Miller CJ J Immunol; 2007 Oct; 179(7):4732-40. PubMed ID: 17878372 [TBL] [Abstract][Full Text] [Related]
10. Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge. Genescà M; Ma ZM; Wang Y; Assaf B; Qureshi H; Fritts L; Huang Y; McChesney MB; Miller CJ J Virol; 2012 Sep; 86(17):9188-200. PubMed ID: 22696662 [TBL] [Abstract][Full Text] [Related]
11. Innate anti-viral immunity is associated with the protection elicited by the simian immunodeficiency virus (SIV) live attenuated virus vaccine in cynomolgus monkeys. Goletti D; Macchia I; Leone P; Pace M; Sernicola L; Pavone-Cossut MR; Maggiorella MT; Cafaro A; Ensoli B; Titti F Med Sci Monit; 2006 Oct; 12(10):BR330-40. PubMed ID: 17006396 [TBL] [Abstract][Full Text] [Related]
12. With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus. Genescà M; Skinner PJ; Hong JJ; Li J; Lu D; McChesney MB; Miller CJ J Virol; 2008 Nov; 82(22):11181-96. PubMed ID: 18787003 [TBL] [Abstract][Full Text] [Related]
13. The majority of CD4+ T-cell depletion during acute simian-human immunodeficiency virus SHIV89.6P infection occurs in uninfected cells. Matrajt L; Younan PM; Kiem HP; Schiffer JT J Virol; 2014 Mar; 88(6):3202-12. PubMed ID: 24390339 [TBL] [Abstract][Full Text] [Related]
14. Protective immune responses induced by a non-pathogenic simian/human immunodeficiency virus (SHIV) against a challenge of a pathogenic SHIV in monkeys. Yoshino N; Ami Y; Someya K; Ando S; Shinohara K; Tashiro F; Lu Y; Honda M Microbiol Immunol; 2000; 44(5):363-72. PubMed ID: 10888354 [TBL] [Abstract][Full Text] [Related]
15. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates. Bertley FM; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A J Immunol; 2004 Mar; 172(6):3745-57. PubMed ID: 15004179 [TBL] [Abstract][Full Text] [Related]
16. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. Egan MA; Chong SY; Megati S; Montefiori DC; Rose NF; Boyer JD; Sidhu MK; Quiroz J; Rosati M; Schadeck EB; Pavlakis GN; Weiner DB; Rose JK; Israel ZR; Udem SA; Eldridge JH AIDS Res Hum Retroviruses; 2005 Jul; 21(7):629-43. PubMed ID: 16060834 [TBL] [Abstract][Full Text] [Related]
17. Protection by live, attenuated simian immunodeficiency virus against heterologous challenge. Wyand MS; Manson K; Montefiori DC; Lifson JD; Johnson RP; Desrosiers RC J Virol; 1999 Oct; 73(10):8356-63. PubMed ID: 10482586 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination. Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414 [TBL] [Abstract][Full Text] [Related]
19. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques. Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675 [TBL] [Abstract][Full Text] [Related]
20. Protection of macaques against a SHIV with a homologous HIV-1 Env and a pathogenic SHIV-89.6P with a heterologous Env by vaccination with multiple gene-deleted SHIVs. Ui M; Kuwata T; Igarashi T; Ibuki K; Miyazaki Y; Kozyrev IL; Enose Y; Shimada T; Uesaka H; Yamamoto H; Miura T; Hayami M Virology; 1999 Dec; 265(2):252-63. PubMed ID: 10600597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]